UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 23, 2023

Accession Number:	0001104659-23-110512
Submission Type:	POS AM
CIK: 0001541157 Company Name: Akari Therapeutics Plc File Number: 333-267840